Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Allergic Rhinitis Market?

In recent times, the market size for allergic rhinitis has seen consistent growth. Projected to increase from $15.22 billion in 2024 to $15.69 billion in 2025, this represents a compound annual growth rate (CAGR) of 3.1%. Factors influencing this growth during the historical period include allergen exposure, transformations in the environment, heightened public awareness, increased pollution, progress in research and development in the realm of allergic rhinitis, and a rise in disposable incomes.

In the forthcoming years, the market size for allergic rhinitis is projected to witness gradual expansion. The growth is expected to reach $18.53 billion in 2029, with a compound annual growth rate (CAGR) of 4.3%. Various factors contributing to the growth during the forecast period include increasing demand for preventative treatments, rising older population, increased urbanization, and healthcare expenditure. Key trends during this period include the use of biologics and monoclonal antibodies, embracing digital health solutions, implementing allergen avoidance strategies, a focus on pediatric allergic rhinitis, and advancements in allergen detection technology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Allergic Rhinitis Market?

The expansion of the allergic rhinitis market is anticipated to be driven by increasing air pollution levels and changing climate conditions. Air pollution, which is characterized by the detrimental substances present in the planet’s atmosphere, poses a significant threat to human health, environmental stability, and overall air quality. Climate change, on the other hand, involves enduring shifts in the Earth’s weather patterns, including changes in temperature, rainfall, and other climatic elements. The impact of air pollution as a key environmental factor in escalating the incidence and severity of allergic rhinitis has been acknowledged increasingly, underlining the complex link between air quality and respiratory wellbeing. For example, the United States Environmental Protection Agency, a regulatory authority of the US government, reported in August 2024 that around 66 million tons of harmful substances had been expelled into the US atmosphere during 2023. Thus, the rising levels of air pollution and the effects of climate change actively contribute to the growth of the allergic rhinitis market.

What Are The Key Segment Trends Observed In The Allergic Rhinitis Market?

The allergic rhinitismarket covered in this report is segmented –

1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis

2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments

3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count

4) By Route Of Administration: Oral; Nasal; Other Route Of Administration

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores

Subsegments:

1) By Seasonal Allergic Rhinitis: Pollen Allergy; Mold Allergy

2) By Perennial Allergic Rhinitis: Dust Mite Allergy; Pet Allergy; Mold Allergy

3) By Occupational Allergic Rhinitis: Chemical Allergens; Biological Allergens

Which Long-Term Trends Will Play A Crucial Role In The Allergic Rhinitis Market?

Notable companies in the allergic rhinitis market are producing pioneering drugs to maintain their market stance. For example, in August 2022, Hikma Pharmaceuticals PLC, a pharmaceutical company from the UK, and Glenmark Specialty S.A., a pharmaceutical firm based in Switzerland, received approval from the United States Food and Drug Administration (FDA), a US federal entity, for their product Ryaltris. This is the inaugural fixed-dose combination medication designed to alleviate nasal and eye symptoms of seasonal allergic rhinitis through an easy-to-use nasal spray for adults and children 12 years old and above. The reduction of nasal symptoms begins to manifest within 15 minutes after the initial dose.

Who Are The Leading Companies Driving The Allergic Rhinitis Market?

Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Which Region Is Forecasted To Lead The Allergic Rhinitis Market In The Coming Years?

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12926&type=smp

Browse Through More Reports Similar to the Global Allergic Rhinitis Market 2025, By The Business Research Company

Allergy Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Allergy Conjunctivitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/allergy-conjunctivitis-global-market-report

House Dust Mite Allergy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model